Published in Ann Oncol on August 22, 2011
The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer. Cell Cycle (2012) 1.56
Treatment of muscle invasive bladder cancer in the elderly: navigating the trade-offs of risk and benefit. World J Urol (2015) 1.04
Muscle-invasive urothelial bladder cancer: an update on systemic therapy. Ther Adv Urol (2015) 0.98
Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review. BMC Cancer (2014) 0.95
Delivering high-quality care to patients with muscle-invasive bladder cancer: Insights from routine practice in Ontario. Can Urol Assoc J (2014) 0.93
Dual targeting of heat shock proteins 90 and 70 promotes cell death and enhances the anticancer effect of chemotherapeutic agents in bladder cancer. Oncol Rep (2014) 0.89
Oncologic outcomes obtained after neoadjuvant and adjuvant chemotherapy for the treatment of urothelial carcinomas of the upper urinary tract: a review. World J Urol (2012) 0.86
Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy. World J Urol (2014) 0.85
ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy. BMC Cancer (2012) 0.83
Adjuvant Chemotherapy Correlates with Improved Survival after Radical Cystectomy in Patients with pT3b (Macroscopic Perivesical Tissue Invasion) Bladder Cancer. J Cancer (2015) 0.82
Systemic therapy for bladder cancer - a medical oncologist's perspective. J Solid Tumors (2014) 0.82
Adjuvant chemotherapy is associated with decreased mortality after radical cystectomy for locally advanced bladder cancer. World J Urol (2014) 0.82
Neoadjuvant paradigm for accelerated drug development: an ideal model in bladder cancer. Oncologist (2013) 0.82
Controversies in the treatment of invasive urothelial carcinoma: a case report and review of the literature. BMC Urol (2015) 0.81
Multimodal management of muscle-invasive bladder cancer. Curr Probl Cancer (2014) 0.81
Systemic, perioperative management of muscle-invasive bladder cancer and future horizons. Nat Rev Clin Oncol (2016) 0.81
Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma. Clin Genitourin Cancer (2015) 0.79
Prognostic features for quality of life after radical cystectomy and orthotopic neobladder. Int Braz J Urol (2016) 0.78
Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer. Transl Androl Urol (2015) 0.77
[Not Available]. Can Urol Assoc J (2014) 0.75
SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016). Clin Transl Oncol (2016) 0.75
Systemic therapy for bladder cancer finally comes into a new age. Future Oncol (2016) 0.75
The Role of Population-Based Observational Research in Bladder Cancer. Bladder Cancer (2015) 0.75
Systemic therapy in bladder cancer. Indian J Urol (2017) 0.75
Perioperative and Maintenance Therapy After First-Line Therapy as Paradigms for Drug Discovery in Urothelial Carcinoma. Clin Genitourin Cancer (2015) 0.75
Clinical role of additional adjuvant chemotherapy in patients with locally advanced urothelial carcinoma following neoadjuvant chemotherapy and cystectomy. World J Urol (2016) 0.75
Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet (2005) 2.95
MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol (2008) 2.76
Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nat Genet (1994) 2.55
Guidelines on urolithiasis. Eur Urol (2001) 2.28
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. J Clin Oncol (2001) 2.21
Zn(II) dependence of the Aeromonas hydrophila AE036 metallo-beta-lactamase activity and stability. Biochemistry (1997) 2.11
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet (2015) 2.05
Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res (2008) 2.00
Central diabetes insipidus in children and young adults. N Engl J Med (2000) 1.97
Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol (2001) 1.96
Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer. J Clin Oncol (2005) 1.85
Efficacy of sacral nerve stimulation for fecal incontinence: results of a multicenter double-blind crossover study. Ann Surg (2005) 1.84
A new phalloplasty technique: the free anterolateral thigh flap phalloplasty. J Plast Reconstr Aesthet Surg (2006) 1.80
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood (2000) 1.79
Wernicke encephalopathy: MR findings at clinical presentation in twenty-six alcoholic and nonalcoholic patients. AJNR Am J Neuroradiol (2007) 1.72
Attitudes toward euthanasia of physician members of the Italian Society for Palliative Care. Ann Oncol (1996) 1.71
Effectiveness of continuous wound infusion of 0.5% ropivacaine by On-Q pain relief system for postoperative pain management after open nephrectomy. Br J Anaesth (2008) 1.70
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Oncogene (2011) 1.69
Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration. Int J Radiat Oncol Biol Phys (1998) 1.68
Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT. Nat Genet (1999) 1.65
Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol (2003) 1.64
Quality-of-life evaluation: when do terminal cancer patients and health-care providers agree? J Pain Symptom Manage (1998) 1.64
Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol (2000) 1.59
Quantitative evaluation of Epstein-Barr-virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. N Engl J Med (1977) 1.59
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival. Lancet (1996) 1.58
A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder Cancer. Eur J Cancer (1998) 1.55
Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder. Ann Oncol (1999) 1.53
Use of discriminant analysis to assess disease activity in pulmonary tuberculosis with a panel of specific and nonspecific serum markers. Am J Clin Pathol (1994) 1.52
Prevention of medication overuse in patients with migraine. Pain (2010) 1.51
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study. J Clin Oncol (1999) 1.51
Academic skills in children with early-onset type 1 diabetes: the effects of diabetes-related risk factors. Dev Med Child Neurol (2012) 1.48
Short- and long-term effects of 186Re-1,1-hydroxyethylidene diphosphonate in the treatment of painful bone metastases. J Nucl Med (2000) 1.47
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial. Ann Oncol (2006) 1.47
Video laparoscopic excision of a seminal vesicle cyst associated with ipsilateral renal agenesis. J Urol (1995) 1.45
Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study. J Clin Oncol (1994) 1.44
Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian study. Ann Oncol (1994) 1.43
Lumbar disk herniation: MR imaging assessment of natural history in patients treated without surgery. Radiology (1992) 1.42
Characterization of a new TEM-derived beta-lactamase produced in a Serratia marcescens strain. Antimicrob Agents Chemother (1997) 1.42
Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res (1997) 1.42
Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study. J Clin Oncol (1992) 1.42
Predictive factors for outcome in invasive bladder cancer treated with alternating chemoradiotherapy. Cancer J Sci Am (1997) 1.38
Does low-molecular-weight heparin influence cancer-related mortality? Ann Oncol (2006) 1.38
Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study. Cancer (1995) 1.35
Reconstitution of cyclin D1-associated kinase activity drives terminally differentiated cells into the cell cycle. Mol Cell Biol (2001) 1.32
Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother (1996) 1.28
Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharmacol Ther (2003) 1.24
Quality of life assessment and outcome of palliative care. J Pain Symptom Manage (2001) 1.24
The effect of extend of caval resection in the treatment of inferior vena cava leiomyosarcoma. Anticancer Res (1998) 1.22
Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid. Allergy (2005) 1.22
Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest (2005) 1.22
Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC). Br J Cancer (2005) 1.18
A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia (2001) 1.16
Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood (1999) 1.15
Predictors of high level of burden and distress in caregivers of demented patients: results of an Italian multicenter study. Int J Geriatr Psychiatry (2005) 1.15
Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial. Neurology (2010) 1.15
Diagnosis and treatment of primary lymphedema. Consensus document of the International Union of Phlebology (IUP)-2009. Int Angiol (2010) 1.14
Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine. Ann Oncol (2010) 1.14
Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies. Oncogene (2001) 1.12
Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan. J Infect Chemother (2006) 1.11
Terminal cancer patients and timing of referral to palliative care: a multicenter prospective cohort study. Italian Cooperative Research Group on Palliative Medicine. J Pain Symptom Manage (1999) 1.10
Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer. J Clin Oncol (1998) 1.10
Prognostic factors influencing cisplatin-induced emesis. Definition and validation of a predictive logistic model. Cancer (1989) 1.10
Local recurrence after curative resection for colorectal cancer: frequency, risk factors and treatment. J Surg Oncol Suppl (1991) 1.10
International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost (2007) 1.10
Phase-II study of Navelbine in advanced breast cancer. Semin Oncol (1989) 1.09
Prognostic relevance of altered Fas (CD95)-system in human breast cancer. Int J Cancer (2000) 1.08
Kinetic study of interaction between BRL 42715, beta-lactamases, and D-alanyl-D-alanine peptidases. Antimicrob Agents Chemother (1995) 1.07
Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas. J Clin Oncol (1998) 1.06
Adoptive immunotherapy of human cancer: the cytokine cascade and monocyte activation following high-dose interleukin 2 bolus treatment. Cancer Res (1990) 1.05
PER-1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa and Acinetobacter spp. FEMS Microbiol Lett (2005) 1.04
Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer. Ann Oncol (2004) 1.04
A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer. J Clin Oncol (1986) 1.04
BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition. Oncogene (2012) 1.03
Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial. Lung Cancer (2001) 1.02
Hemodilution therapy with hydroxyethyl starch solution (130/0.4) in unilateral idiopathic sudden sensorineural hearing loss: a dose-finding, double-blind, placebo-controlled, international multicenter trial with 210 patients. Otol Neurotol (2007) 1.01
Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort. Eur J Surg Oncol (2013) 1.01
VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. J Clin Oncol (1998) 1.00
Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade. Med Mycol (2012) 1.00
EPEC, EAEC and STEC in stool specimens: prevalence and molecular epidemiology of isolates. Diagn Microbiol Infect Dis (2001) 0.99
Addictive illegal drugs: structural neuroimaging. AJNR Am J Neuroradiol (2009) 0.99
Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O. Eur J Surg Oncol (2010) 0.99
Localization, by linkage analysis, of the cystinuria type III gene to chromosome 19q13.1. Am J Hum Genet (1997) 0.98
Staghorn calculi of the kidney: classification and therapy. Br J Urol (1990) 0.98
A novel H572R mutation in the transforming growth factor-beta-induced gene in a Thai family with lattice corneal dystrophy type I. Jpn J Ophthalmol (2006) 0.98
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis. Ann Oncol (2011) 0.97
Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites. Allergy (2003) 0.97
Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: The G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly. Anticancer Res (1995) 0.97
Prevalence of papillomavirus, Epstein-Barr virus, cytomegalovirus, and herpes simplex virus type 2 in urinary bladder cancer. J Med Virol (1998) 0.96
Volatile organic compounds in exhaled breath in a healthy population: effect of tobacco smoking. Arch Bronconeumol (2013) 0.96
Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion. Cancer (1989) 0.96
Magnetic resonance imaging findings of amygdala-anterior hippocampus shrinkage in male patients with schizophrenia. Psychiatry Res (1994) 0.96
Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer. Br J Cancer (2009) 0.96